- Home
- XNCR vs OFIX Comparison
XNCR vs OFIX Comparison
Compare XNCR & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- OFIX
- Stock Information
- Founded
- XNCR 1997
- OFIX 1987
- Country
- XNCR United States
- OFIX United States
- Employees
- XNCR N/A
- OFIX N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- XNCR Health Care
- OFIX Health Care
- Exchange
- XNCR Nasdaq
- OFIX Nasdaq
- Market Cap
- XNCR 547.8M
- OFIX 564.4M
- IPO Year
- XNCR 2013
- OFIX N/A
- Fundamental
- Price
- XNCR $13.61
- OFIX $14.57
- Analyst Decision
- XNCR Buy
- OFIX Strong Buy
- Analyst Count
- XNCR 11
- OFIX 5
- Target Price
- XNCR $22.20
- OFIX $21.75
- AVG Volume (30 Days)
- XNCR 1.3M
- OFIX 286.7K
- Earning Date
- XNCR 11-05-2025
- OFIX 11-06-2025
- Dividend Yield
- XNCR N/A
- OFIX N/A
- EPS Growth
- XNCR N/A
- OFIX N/A
- EPS
- XNCR N/A
- OFIX N/A
- Revenue
- XNCR $146,929,000.00
- OFIX $809,030,000.00
- Revenue This Year
- XNCR $23.31
- OFIX $3.88
- Revenue Next Year
- XNCR N/A
- OFIX $5.59
- P/E Ratio
- XNCR N/A
- OFIX N/A
- Revenue Growth
- XNCR N/A
- OFIX 4.84
- 52 Week Low
- XNCR $6.92
- OFIX $10.24
- 52 Week High
- XNCR $27.24
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- XNCR 88.43
- OFIX 53.06
- Support Level
- XNCR $11.36
- OFIX $13.99
- Resistance Level
- XNCR $13.07
- OFIX $14.42
- Average True Range (ATR)
- XNCR 0.63
- OFIX 0.40
- MACD
- XNCR 0.16
- OFIX -0.05
- Stochastic Oscillator
- XNCR 94.92
- OFIX 60.73
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.